Skip to content
TrialScanner

NCT05081245

ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)

Phase 2CompletedMPLTLead

Registry record

Lead sponsor
MapLight Therapeutics
Conditions
Autism Spectrum Disorder
Primary completion
Mar 10, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05081245 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05081245: ML-004 in Adolescents and... | TrialScanner